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Heparan sulfate interacts with antithrombin, a prote-
ase inhibitor, to regulate blood coagulation. Heparan
sulfate 3-O-sulfotransferase isoform 1 performs the cru-
cial last step modification in the biosynthesis of antico-
agulant heparan sulfate. This enzyme transfers the
sulfuryl group (SO3) from 3-phosphoadenosine 5-phos-
phosulfate to the 3-OH position of a glucosamine residue
to form the 3-O-sulfo glucosamine, a structural motif
critical for binding of heparan sulfate to antithrombin.
In this study, we report the crystal structure of 3-O-
sulfotransferase isoform 1 at 2.5-Å resolution in a binary
complex with 3-phosphoadenosine 5-phosphate. This
structure reveals residues critical for 3-phosphoad-
enosine 5-phosphosulfate binding and suggests resi-
dues required for the binding of heparan sulfate. In
addition, site-directed mutagenesis analyses suggest
that residues Arg-67, Lys-68, Arg-72, Glu-90, His-92, Asp-
95, Lys-123, and Arg-276 are essential for enzymatic ac-
tivity. Among these essential amino acid residues, we
find that residues Arg-67, Arg-72, His-92, and Asp-95 are
conserved in heparan sulfate 3-O-sulfotransferases but
not in heparan N-deacetylase/N-sulfotransferase, sug-
gesting a role for these residues in conferring substrate
specificity. Results from this study provide information
essential for understanding the biosynthesis of antico-
agulant heparan sulfate and the general mechanism of
action of heparan sulfate sulfotransferases.
Heparan sulfate (HS)1 is widely expressed in animal and
human tissues. It has diverse roles in development, assisting
viral infections, and homeostasis (1–3). HS is a highly sulfated
polysaccharide consisting of 1–4-linked sulfated glucosamine
and sulfated glucuronic/iduronic acid residues. The specific
sequences of sulfated saccharide in HS determine its various
functions.
Synthesis of biologically active HS is accomplished through a
complex biosynthetic pathway. HS is initially synthesized as a
copolymer of glucuronic acid and N-acetylated glucosamine by
D-glucuronyl and N-acetyl-D-glucosaminyltransferase followed
by various modifications in the Golgi apparatus (4). These
modifications include N-deacetylation and N-sulfonation of glu-
cosamine, C5 epimerization of glucuronic acid to form iduronic
acid residues, and 2-O-sulfonation of iduronic and glucuronic
acid residues as well as 6-O-sulfonation and 3-O-sulfonation of
the glucosamine units. The stepwise sulfonation reactions are
illustrated in Fig. 1. All of the enzymes that are responsible for
the biosynthesis of HS have been cloned and characterized (5).
The blood coagulation pathway is composed of a cascade of
proteolytic reactions ultimately generating fibrin thrombi. The
proanticoagulant activity of this cascade is balanced by several
natural anticoagulant mechanisms. Binding of HS to anti-
thrombin (AT) represents the most important of these mecha-
nisms. HS achieves its anticoagulant activity by interacting
with AT, which undergoes a conformation change, generating
the active form of AT to inhibit blood coagulation factors Xa
and thrombin. This anticoagulant process prevents the forma-
tion of deleterious blood clots. Heparin, a specialized HS found
in mast cells, is the most commonly used anticoagulant drug.
Anticoagulant HS and heparin contain structurally defined
AT binding pentasaccharide sequences with the structure, -Gl-
cNS(or Ac)6S-GlcUA-GlcNS3S6S-IdoUA2S-GlcNS6S- (Gl-
cUA is glucuronic, and IdoUA is iduronic acid) (Fig. 1) (6). The
3-O-sulfo glucosamine unit (GlcNS3S6S) in this binding site
is essential for interaction with AT. The lack of a 3-O-sulfo
group in this unit decreases AT binding affinity by 18,000-fold
(6). A recently approved anticoagulant drug, Arixtra, prepared
by organic synthesis is based on this pentasaccharide scaffold.
The recently reported enzymatic synthesis of a similar pen-
tasaccharide utilizes 3-OST-1 in the last modification step
(5) and opens up a new approach to preparation of such
anticoagulants.
The essential physiological role of 3-O-sulfo HS (or anticoag-
ulant HS) in blood coagulation is best demonstrated through
the study of AT and AT mutants. A severe thrombosis pheno-
type is observed in mice carrying an AT mutant defective in
heparin binding, suggesting a key role for HS-AT interaction in
balancing procoagulant and anticoagulant activities in vivo (7).
Additionally, patients with AT mutants defective in heparin
and HS binding suffer from thrombosis (8–10). Furthermore, it
appears that complete ablation of AT-HS binding is required to
* This work was supported in part by National Institutes of Health
Grant AI50050 (to J. L.) and American Heart Association Mid-Atlantic
Affiliate Grant-in-aid 0355800U (to J. L.). The costs of publication of
this article were defrayed in part by the payment of page charges. This
article must therefore be hereby marked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and structure factors (code 1S6T) have been
deposited in the Protein Data Bank, Research Collaboratory for Struc-
tural Bioinformatics, Rutgers University, New Brunswick, NJ
(http://www.rcsb.org/).
** To whom correspondence and reprint requests should be ad-
dressed: Rm. 309, Beard Hall, University of North Carolina, Chapel
Hill, NC 27599. Tel: 919-843-6511; Fax: 919-843-5432; E-mail:
jian_liu@unc.edu.
1 The abbreviations used are: HS, heparan sulfate; AT, antithrombin;
3-OST, 3-O-sulfotransferase; PAPS, 3-phosphoadenosine 5-phospho-
sulfate; PAP, 3-phosphoadenosine 5-phosphate; PSB, phosphosulfate
binding; NST-1, N-deacetylase/N-sulfotransferase; Tricine, N-[2-hy-
droxy-1,1-bis(hydroxymethyl)ethyl]glycine; ITC, isothermal titration
calorimetry; MOPS, 4-morpholinepropanesulfonic acid; WT, wild type.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 279, No. 24, Issue of June 11, pp. 25789–25797, 2004
Printed in U.S.A.
This paper is available on line at http://www.jbc.org 25789
This is an Open Access article under the CC BY license.
reveal the full physiological role of anticoagulant HS in vivo
(11). The final step in the biosynthesis of anticoagulant HS can
be catalyzed by either 3-OST-1 or 3-OST-5 isoforms (12, 13).
Gene redundancy in the biosynthesis of anticoagulant HS helps
to explain why 3-OST-1 knockout mice failed to exhibit a pro-
thrombotic phenotype (14).
Heparan sulfate 3-O-sulfotransferase (3-OST) is present in
at least six different isoforms that have unique expression
patterns in human tissues (15, 16). The amino acid sequences
of the different isoforms have 50–80% homology in their sul-
fotransferase domains (15). These different 3-OST isoforms
transfer sulfuryl groups to the 3-OH position of glucosamine
units residing within the context of different saccharide se-
quences. As a result, the HS products generated by these dif-
ferent isoforms exhibit unique and distinctive biological activ-
ities. It is known that HS modified by 3-OST-1 and 3-OST-5
display anticoagulant activity, whereas HS modified by
3-OST-3 and 3-OST-5 serve as entry receptors for herpes sim-
plex virus-1 (12, 16, 17). The structural features of 3-OST
isoforms that dictate substrate specificity are currently
unknown.
The sulfotransferase family can be organized into two cate-
gories based on the sub-cellular localizations; they are cytosolic
and Golgi sulfotransferases (18, 19). The crystal structures of
different sulfotransferases reveal structural similarity in their
PAPS binding sites between the cytosolic and Golgi sulfotrans-
ferases, suggesting that different sulfotransferases probably
follow similar mechanisms in the transfer of the sulfuryl group
even though they exhibit high selectivity in substrate binding
(20, 21). The structures of a number of cytosolic sulfotrans-
ferases complexed with acceptor substrates have been solved,
providing clues that have led to a better understanding of their
catalytic mechanism and mode of substrate recognition (22–
24). HS sulfotransferases are considered to be Golgi sulfotrans-
ferases. The crystal structure of the binary complex of the
sulfotransferase domain of the HS N-deacetylase/N-sulfotrans-
ferase (NST-1) and 3-phosphoadenosine 5-phosphate (PAP)
was solved by Kakuta et al. (21). This represents the first and
only structure of a HS sulfotransferase previously determined.
In this study, we report the crystal structure of a binary
complex of mouse 3-OST-1 and PAP. The structure of this
enzyme is very similar to NST-1 but with unique structural
features in the HS binding cleft. Results from mutational anal-
ysis of amino acid residues at and around the active site in
FIG. 1. The schematic biosynthesis
of anticoagulant heparan sulfate.
Five steps are involved in the biosynthe-
sis of HS after the polysaccharide back-
bone is made. The numbers indicate the
positions of each sugar unit. Both
N-deacetylase/N-sulfotransferase and C5-
epimerase modifications are indicated in
red. The 2-O-sulfotransferase and 6-O-
sulfotransferase modifications are indi-
cated in black and blue, respectively. The
3-O-sulfotransferase modification is indi-
cated in purple. For clarity, we have indi-
cated the 3-O-sulfotransferase isoform 1
modifications only in this figure. GlcUA,
glucuronic; IdoUA, iduronic acid; Glc,
glucosamine.
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3-OST-1 reveal a series of amino acid residues that is critical
for sulfotransferase activity. These results, when combined
with a structural alignment to NST-1 and sequence alignments
to other isoforms of 3-OST, provide insight into the role certain
residues may play in catalysis and dictating substrate specific-
ity for these HS sulfotransferases.
EXPERIMENTAL PROCEDURES
Materials—Full-length mouse 3-OST-1 cDNA (m3-OST-1-pcDNA3)
was purified from a mouse L-cell cDNA library (25). [35S]PAPS was
prepared by incubating 0.4–2 mCi/ml [35S]Na2SO4 (carrier-free, MP
Biomedical) and 16 mM ATP with 5 mg/ml dialyzed yeast extract
(Sigma) (26). HS from bovine kidney was purchased from MP Biomed-
ical (Irvine, CA). PAP was purchased from Sigma.
Expression, Purification, and Crystallization of 3-OST-1
Preparation of 3-OST-1 Bacterial Expression Plasmid (b3-OST-1-
pET28)—The cDNA fragment encoding the catalytic domain of 3-OST-1
(G48-H311) was amplified from m3-OST-1-pcDNA3 with a 5 overhang
containing an NdeI site and a 3 overhang containing an EcoRI site.
This construct was inserted into the pET28a vector (Novagen) using the
NdeI and EcoRI restriction sites to produce a His6-tagged protein. The
resultant plasmid (b3-OST-1-pET28) was sequenced to confirm the
reading frame and the lack of mutations within the coding region
(University of North Carolina, DNA sequencing core facility). The plas-
mid, b3-OST-1-pET28, was transformed into BL21(DE3)RIL cells
(Stratagene) for the expression of 3-OST-1.
Protein Expression and Purification—Cells containing the b3-
OST-1-pET28 were grown in 12 2.8-liter Fernbach flasks containing 1
liter of LB media with 50 g/ml kanamycin at 37 °C. When the A600
reached 0.6–0.8, the temperature was lowered to 22 °C for 15 min.
Isopropyl--D-thiogalactopyranoside was then added to a final concen-
tration of 200 M, and the cells were allowed to shake overnight. Cells
were pelleted and resuspended in 120 ml of sonication buffer, 25 mM
Tris, pH 7.5, 500 mM NaCl, and 10 mM imidazole. Cells were disrupted
by sonication then spun down. The supernatant was applied to nickel
nitrilotriacetic acid-agarose resin (Qiagen) in batch and washed with
sonication buffer. The resin was loaded onto a column, and the protein
was eluted with an imidazole gradient from 10 to 250 mM. The protein
was dialyzed then concentrated to 16 mg/ml in 20 mM Tris, pH 7.5, 100
mM NaCl, and 4 mM PAP. A total of 28 mg of protein was obtained.
Protein Crystallization and Structure Solution—Crystals of 3-OST-1
were grown using the hanging drop method at 4 °C by mixing 2 l of the
protein solution with 2 l of the reservoir solution containing 0.1 M
citrate, pH 5.5, and 11% polyethylene glycol 4000. Before data collec-
tion, crystals were transferred to a solution containing 0.1 M citrate, pH
5.5, 20% polyethylene glycol 4000, 0.1 M NaCl, 4 mM PAP, and 12.5%
ethylene glycol. The crystals were mounted in a loop and flash-frozen in
liquid nitrogen. Data were collected at 180 °C on a RaxisIV area
detector for the low resolution data set. A high resolution data set was
collected on another crystal at the Advanced Photon Source on SER-
CAT beamline 22 using a MAR225 area detector. Both data sets were
processed using HKL2000 (Table I) (27). A model of NST-1 (21) consist-
ing of residues 603–632, 642–664, 670–736, 744–868, and PAP was
used as a search molecule for molecular replacement using Molrep in
CCP4 with the low resolution data set (28, 29). The positions of two (A
and B) of the three final molecules in the asymmetric unit were found
by molecular replacement. These two molecules were refined in CNS
(30) and improved by iterative cycles of model building in O (31) and
refinement in CNS until an Rfree value of 35% was obtained. At this
point, sparse electron density became visible for the third molecule (C).
A copy of molecule A was manually inserted into the density and
refined. Density for molecule C was very poor, and the B-factors were
very high, so refinement was carried out using non-crystallographic
restraints between the third molecule and the first molecule. Residues
for molecule C, which contained no electron density, were deleted.
Refinement of molecule C dropped the Rfree to 31%. The final model was
obtained by iterative cycles of model building and refinement of the
three molecules against the high resolution data set. The final molecule
contains residues 54–311 for molecule A and B and 54–269 and 281–
311 for molecule C.
Mutational Analysis of 3-OST-1
Preparation of 3-OST-1 Mutant Plasmids—A total of 28 point mu-
tants of 3-OST-1 were prepared using b3-OST-1-pET28 as the template
and the Gene Tailor site-directed mutagenesis kit from Invitrogen. The
lengths and sequences of the primers for preparation of those mutants
were designed based on the manufacturer’s protocol for this mutagen-
esis kit and were synthesized by Invitrogen. The resultant constructs
were sequenced to confirm the anticipated mutation (University of
North Carolina, DNA sequencing core facility).
Expression and Purification of 3-OST-1 Mutants—The expression
plasmids for various 3-OST-1 mutants were transformed individually
into BL21(DE3)RIL cells (Stratagene). Each mutant construct was
grown in 100 ml of LB broth and induced by isopropyl--D-thiogalacto-
TABLE I
Crystallographic data statistics
Data set 3-OST-1 (high) 3-OST-1 (low)
Unit cell dimensions a  b  300.14 c  84.20 a  b  298.69 c  83.82
      90°       90°
Space group I4 (1) 22 I4 (1) 22
No. of observations 741,873 180,101
Unique reflections 63,928 43,945
Rsym (%) (last shell)
a 11.6 (37.1) 13.7 (61.5)
I/I (last shell) 7.4 (1.7) 6.7 (1.4)
Mosaicity 0.41 0.62
Completeness (%) (last shell) 96.7 (83.6) 93.9 (82.4)
Refinement statistics





No. of water 178
Mean B value (Å) 58.3
For: Complex A Complex B Complex C
Protein 43.06 39.17 100.69
PAP 31.23 33.18 69.76
Root mean square deviation from ideal valuesd
Bond length (Å) 0.009
Bond angle (°) 1.4
Dihedral angle (°) 22.4
Improper angle (°) 0.95
Ramachandran statistics
94.57% residues are in favored (98%) regions
99.74% residues are in allowed (99.8%) regionse
a Rsym   (Ii  I)/(Ii) where Ii is the intensity of the Ith observation, and I is the mean intensity of the reflection.
b Rcryst  Fo  FoFo calculated from working data set.
c Rfree was calculated from 5% of data randomly chosen not to be included in refinement.
d Ramachandran results were determined by MolProbity.
e Two residues from complex C, which lie outside this region, are in allowed regions based on PROCHECK (28).
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pyranoside as described above. The bacteria cells were harvested and
solubilized in sonication buffer before sonication. The lysate was sub-
jected to a 400-l nickel nitrilotriacetic acid-agarose column (0.75 	 1
cm) followed by a 5-ml of wash with sonication buffer. Mutant proteins
were eluted with 1 ml of elution buffer containing 25 mM Tris, 500 mM
NaCl, and 250 mM imidazole, pH 7.5. Approximately 25 l of the eluent
was subjected to the analysis on a 16.5% Tris-Tricine PAGE gel (Bio-
Rad), and the gel was stained by Coomassie Blue. The expression level
of the mutant protein was estimated by determining the intensity of the
Coomassie-stained protein band near 30 kDa. As a positive control, we
expressed wild type 3-OST-1 (b3-OST-1-pET28) along with the mu-
tants. The expression levels and the sulfotransferase activity of mutant
proteins were normalized to those of wild type protein.
Several clones harboring mutant proteins, including R67E, K68A,
R72E, E90Q, K123A, and R276A, were grown in 2–4-liter cultures to
obtain sufficient amounts of protein for analysis by isothermal titration
calorimetry (ITC). Procedures for expression and purification of these
mutants were essentially identical to those for the wild type 3-OST-1.
Mutant protein was purified by nickel nitrilotriacetic acid-agarose chro-
matography, and purity was estimated to be greater than 80% by a
16.5% Tris-Tricine PAGE gel.
Determination of the Sulfotransferase Activity—Sulfotransferase ac-
tivity was determined by incubating 
5 l (10–100 ng) of purified
mutant or wild type 3-OST-1 proteins with 10 g of HS (from bovine
kidney, ICN) and 5–10 	 104 cpm of [35S]PAPS (
10 M) in 50 l of
buffer containing 50 mM MOPS, pH 7.0, 10 mM MnCl2, 5 mM MgCl2, and
1% Triton X-100. The reaction was incubated at 37 °C for 30 min and
quenched by the addition of 6 M urea and 100 mM EDTA. The sample
was then subjected to a 200-l DEAE-Sepharose chromatography to
purify the [35S]HS. The quantity of [35S]HS was then determined by
liquid scintillation counting. The negative control contained all the
components with the exception of 3-OST-1 proteins.
Determination of the Binding of AT and 3-O-Sulfated HS—Approx-
imately 5 	 106 cpm of [35S]HS was incubated with 5 g of human AT
(Cutter Biological) in 50 l of reaction buffer containing 10 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 1 mM Mn2, 1 mM Mg2, 1 mM Ca2, 10 M
dextran sulfate, 0.02% sodium azide, and 0.0004% Triton X-100 for 30
min at room temperature. 60 l of 1:1 slurry of pretreated concanavalin
A-Sepharose (from Sigma) was added, and the reaction was agitated for
1 h at room temperature on an orbital shaker. The gel was washed three
times with the buffer containing 10 mM Tris-HCl, pH 7.5, 150 mM NaCl,
1 mM Mn2, 1 mM Mg2, 1 mM Ca2, 10 M dextran sulfate, 0.02%
sodium azide, and 0.0004% Triton X-100, and the bound [35S]HS was
eluted with the same buffer containing 1000 mM NaCl.
ITC—ITC was performed on a MicroCal VP-ITC. Solutions were
cooled to 10 °C and degassed under vacuum before use. Experiments
were conducted using 17–21 M protein in 100 mM phosphate buffer, pH
7.0) and 100 mM NaCl at 10 °C. Titrations were performed by injecting
5 l of 4 mM PAP in 100 mM phosphate buffer, pH 7.0, and 100 mM
NaCl. Data analysis was completed using Origin software.
Determination of PAP Binding Affinity Using PAP Chromatogra-
phy—To determine the binding affinity of the wild type and mutant
proteins to PAP, 3,5-ADP-agarose chromatography (Sigma) was used.
Approximately 200 g of proteins, including wild type 3-OST-1, K68A,
H92F, and D95N and R276A, in 5 ml of a buffer containing 25 mM Tris,
pH 7.0, and 100 mM NaCl was loaded onto a 3,5-ADP-agarose column
(7 	 52 mm) pre-equilibrated with 25 mM Tris, pH 7.0, and 100 mM
NaCl at a flow rate of 0.5 ml/min. Unbound material was removed by
FIG. 2. The crystal structure of 3-OST-1 in complex with PAP. a, stereo ribbon diagram of the crystal structure of 3-OST-1. Also pictured
is the donor product PAP and conserved residues Ser-159 and Lys-68 that interact with the 3- and 5-phosphates of PAP, respectively, as well as
residue Glu-90, which has been proposed to be involved in catalysis. b, stereo diagram of the PAPS binding site of 3-OST-1 with PAP bound. The
electron density for PAP from a simulated annealing omit map is drawn contoured at 8 (blue). Superimposed onto the active site are PAPS (pink)
from the crystal structure of human estrogen sulfotransferase (PDB code1HY3) and 17-estradiol, the acceptor substrate, and the catalytic base
His-108 (purple) from mouse estrogen sulfotransferase (PDB code 1AQU). Superpositions are based on the PSB loop of these structures. These
superpositions suggest the position of the sulfuryl group of PAPS in 3-OST-1 binding as well as the position of the acceptor hydroxyl of the heparan
substrate (the 3-hydroxyl on 17-estradiol). Hydrogen bonds between 3-OST-1 and PAP are drawn in dashed black lines as well as the interaction
between His-108 and 17-estradiol in mouse estrogen sulfotransferase. Potential hydrogen bonds between 3-OST-1 residues and the sulfuryl group
of PAPS are shown in dashed orange lines as is the potential interaction between Glu-90 and the acceptor hydroxyl of the substrate. The solid
orange line (labeled with an asterisk) displays the direction of attack of the acceptor hydroxyl on the sulfuryl group for the proposed in-line transfer
reaction mechanism. For this figure the oxygen, nitrogen, and phosphorous atoms are colored red, blue, and magenta, respectively. This figure was
created using Molscript (37) and Raster3D (38).
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washing with 5 ml of 25 mM Tris, pH 7.0, and 100 mM NaCl. Bound
proteins were eluted with a linear gradient of NaCl from 100 mM to 1 M
in 10 ml. The samples from the collected fractions were analyzed by
SDS-PAGE followed by staining with Coomassie Blue.
RESULTS AND DISCUSSION
Overall Fold—The catalytic domain of mouse 3-OST-1 (G48-
H311) was successfully expressed in Escherichia coli. The cat-
alytic domain has higher solubility than the full-length protein,
making it more amenable to crystallization. The 3-OST-1
protein crystallized in the space group I4122 with 3 protein
molecules (A, B, and C) in the asymmetric unit. Each mole-
cule of 3-OST-1 contains one molecule of PAP bound. Two of
the protein molecules (A and B) in the asymmetric unit stack
together, forming hollow channels with the long dimension
running parallel to the c axis of the unit cell. The rim of
the channel is composed of 4 molecules of both A and B. The
hollow inner solvent channel has a diameter of 
62 Å. The
third molecule (C) is involved in cross-linking these channels
by interacting with molecules B and a molecule C coming
from another channel. This packing arrangement creates a
cell with an overall solvent content of 76% and a Matthews
coefficient of 5.5 (32). Molecules A and B are well ordered and
have similar overall B-factors (Table I). Molecule C, however,
is highly disordered, with overall B-factors 
2.5 times
greater than molecules A and B, suggesting it may bind in
slightly different orientations or have only partial occupancy
in the crystal lattice. Because molecule C is highly disor-
dered, the discussion of the structure will focus on molecules
A and B.
The crystal structure of the 3-OST-1PAP complex (Fig. 2a) is
roughly spherical and contains a large open cleft. The structure
is centered around an / motif common to all sulfotrans-
ferases (18). This motif consists of a five-stranded parallel
-sheet flanked on both sides by  helices. At the heart of the
fold is a strand-loop-helix motif (Thr-61–Ser-79) consisting of
the first -strand (The-61–Ile-64) and the first -helix (Thr-71–
Ser-79), which contains the phosphosulfate binding (PSB) loop
(Gly-65–Gly-70) (22). This loop is very similar in structure to
the P-loop found in protein kinases and forms extensive inter-
actions with the 5-phosphate of the PAP (Fig. 2b). As in other
sulfotransferases, the helix that runs across the top of the PAP
binding pocket and into the open cleft is also present. The
C-terminal portion of the enzyme consists of a short three-
TABLE II
Distance between PAP and free SO4
2 to 3-OST-1 residues
All distances are based on PAP bound to molecule B. The His-278
interaction does not exist in molecule A.
Interactions with PAP
Residue Atom PAP atom Distance
Å
5-Phosphate
Lys-68 NZ O6P 2.8
Lys-274 NZ O6P 3.0
Gly-70 N O4P 3.0
Thr-71 N O4P 2.6
Thr-71 N O4P 2.6
Arg-72 N O5P 3.1
Lys-274 NZ O5P 3.1
G70 Gly-70 N O5 3.1
3-Phosphate
Arg-151 NH2 O3 3.1
Ser-159 OG O2P 2.6
His-278 NE2 O2P 3.1
Gly-275 N O3P 2.7
Arg-276 N O3P 3.1
Adenine base
Tyr-259 O N6 3.0
Interactions with free SO4




Arg-72 NH1 O4 2.8
Lys-123 NZ O4 3.2
Lys-274 NZ O3 2.8
FIG. 3. The superimposed struc-
tures of NST-1 and 3-OST-1. a, stereo
diagram of the C trace of the crystal
structures of 3-OST-1 (green, PAP is in
orange) with the sulfotransferase domain
of NST-1 (pink) (PDB code 1NST). This
figure clearly shows the large open cleft of
the proposed heparan binding site. b, ste-
reo diagram of the superposition of the
active sites of 3-OST-1 and NST-1. Al-
though the overall fold is similar, residues
lining the cleft are quite different. In both
panels a and b the loop unique to NST
from residues 633 to 641 is colored blue.
Glu-641 is labeled for clarity. For this fig-
ure the oxygen, nitrogen, and phospho-
rous atoms are colored red, blue, and
magenta, respectively. This figure was
created using Molscript (37) and
Raster3D (38).
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stranded anti-parallel -sheet. Strands 2 and 3 of this sheet are
stabilized by a disulfide bond (Cys-260–Cys-269). A coil con-
sisting of residues 270–281 connects this sheet to the C-termi-
nal helix. This coil practically buries the PAP molecule in the
active site and may be susceptible to a conformational change
since it is ordered in molecules A and B and there is no electron
density visible for it in molecule C.
The overall fold of 3-OST-1 is most similar to that of the
sulfotransferase domain of NST-1 (21) (Fig. 3a). The root mean
square of 230 structurally equivalent Cs is 1.3 Å, as deter-
mined by the program O (31). All of the significant secondary
structural features are conserved between the two enzymes.
The major differences occur in the loop regions as described
below.
PAP Binding Site—A number of hydrogen-bonding interac-
tions are involved in positioning the PAP molecule within the
active site (Fig. 2b). Side chains from residues Lys-68 and
Thr-71 of the PSB loop and Lys-274 of the coil that buries the
PAP both form interactions with the 5-phosphate (Table II). In
addition, backbone amide nitrogens from the PSB loop (Gly-70,
Thr-71, and Arg-72) are also within hydrogen-bonding distance
of the 5-phosphate. Although there are no protein interactions
with the ribose ring, atom N6 of the adenosine base is within
hydrogen-bonding distance to the carbonyl oxygen of Tyr-259.
In addition, residues Phe-258, Ile-225, Ala-73, and Leu-270 are
all within 4 Å of the base and assist in positioning the base
through van der Waals forces.
Like the 5-phosphate binding site, the 3-phosphate also
forms a number of interactions with the protein. The side chain
of Arg-151 is within hydrogen-bonding distance to the bridging
O3 oxygen. In addition, the side chain oxygen of Ser-159 also
lies within hydrogen-bonding distance of Arg-151 as well as
FIG. 4. Alignment of mouse 3-OST-1 with human 3-OST-5, 3-OST-3A, and NST-1. NST-1 alignment is based on the structural alignment
with 3-OST-1. Regions with yellow background are structurally dissimilar. Mutants of residues in red, knockout activity in 3-OST-1, 2% WT
activity (orange), 10% WT (green), and 10% WT (blue). Residues in purple form a disulfide bond. NST-1 amino acids labeled by a red asterisk
indicate amino acid mutants with no activity, and green asterisk-labeled residues have greatly reduced activity (results are taken from Kakuta et
al. (34)). The percentage of amino acid identity with 3-OST-1 is shown in the bottom right corner of this figure.
FIG. 5. Charged surface diagram of the proposed heparan binding cleft of the sulfotransferase domains of NST-1 (a) and 3-OST-1
(b). The global position of the cleft is marked with a green dashed line. Blue surfaces signify positive charge, whereas red surfaces signify negative
charge. The double-sided dash arrows (in green) indicate the region where HS may bind. This figure was created using Swiss PDB viewer.
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with a 3-phosphate oxygen. Backbone amides from residues
Gly-275 and Arg-276 of the flexible loop also form interactions
with the phosphate. In molecule B, atom NE2 of the side
chain from His-278 is within hydrogen-bonding distance of
the phosphate as well; however, this residue has a different
conformation in molecule A and consequently is not near the
phosphate.
Catalytic Mechanism—Heparan sulfotransferases, including
3-OST-1 and NST-1, and cytosolic sulfotransferases recognize
substrates that have distinct chemical structures. Based on
structural similarities and utilization of the same sulfuryl do-
nor, PAPS, it is believed that heparan sulfotransferases and
cytosolic sulfotransferases share a common mechanism (33).
Superposition of 3-OST-1 with structures of estrogen sulfo-
transferase, a representative cytosolic sulfotransferase, with
PAPS and 17-estradiol bound depicts the catalytic functions
of the key amino acid residues for the activities of 3-OST-1 and
estrogen sulfotransferase (Fig. 2b). The mechanism of the cy-
tosolic sulfotransferases has been suggested to proceed through
an SN2-like in-line displacement mechanism whereby the ac-
ceptor hydroxyl acts as a nucleophile, which when deproto-
nated by a conserved histidine attacks the sulfur atom of PAPS
(20, 22). This creates a trigonal bi-pyramidal transition state
with the PAP and acceptor group in the axial positions. The
negative charge build up on the leaving PAP group is stabilized
by a conserved lysine residue on the PSB loop that forms a
hydrogen bond with the bridging oxygen to the sulfur atom.
This lysine is in a similar conformation in both the structures
of estrogen sulfotransferase in complex with PAP and 17-
estradiol and 3-OST-1 in complex with PAP. Interestingly, in
the estrogen sulfotransferase-PAPS binary complex, the lysine
lies in a different conformation and forms a hydrogen bond with
a conserved serine that also forms hydrogen bonds with the
3-phosphate of PAP (24). This interaction may be essential for
all sulfotransferases to reduce the rate of hydrolysis of PAPS in
the absence of acceptor substrate.
The lysine and serine residues, which are used by estrogen
sulfotransferase to position and stabilize PAPS, are conserved
in NST-1 (Lys-614, Ser-712) as well as in the 3-OSTs including
3-OST-1 (Lys-68, Ser-159, respectively) (Fig. 2b). The catalytic
base, however, is not conserved between the estrogen sulfo-
transferase and the heparan sulfotransferases. The heparan
sulfotransferases do not contain a residue structurally equiva-
lent to the catalytic histidine found in cytosolic sulfotrans-
ferases such as the estrogen sulfotransferases. However, a
conserved glutamate is located at a different position in the
catalytic sites of NST-1 (Glu-642) and 3-OST-1 (Glu-90) (Fig.
2b). This glutamate residue was proposed to serve as the cat-
alytic base for the activity of NST-1 (33, 34). In both 3-OST-1
and NST-1 structures, this glutamate is found on the inside of
the large cleft. Mutation at Glu-90 of 3-OST-1 results in com-
plete loss of sulfotransferase activity as described below, sug-
gesting that Glu-90 is critical for the catalytic function
of 3-OST-1.
Heparan Sulfate Binding Site—The large open cleft of the
3-OST-1 structure is believed to be the HS binding site (Fig 3a).
This hypothesis is based on the fact that this open cleft in
NST-1 has been shown to accommodate a hexasaccharide and
provides access to the sulfuryl group of PAPS, where the sul-
fotransfer reaction occurs (34). Despite the overall fold of these
two enzymes being similar, the cleft of 3-OST-1 differs from
that of NST-1 in both the primary amino acid sequence and the
distribution of the positively charged amino acid residues.
NST-1 contains an insertion immediately before the catalytic
base (residues Asn-633—Glu-641) that does not exist in
3-OST-1 molecules (Figs. 3b and 4). Mutations from this loop
F640A and E641A have a significant effect on NST-1 activity
(34). Because these residues are not conserved in the 3-OSTs, it
is unlikely that this loop of NST-1 plays a fundamental role in
catalysis of all HS sulfotransferase reaction. Therefore, it is
possible that this NST-1-specific loop helps the enzyme to rec-
ognize NST-1-specific saccharide units within its polysaccha-
ride substrate (the structures of NST-1 and 3-OST-1 substrates
are shown in Fig. 1).
The majority of the residues that line this cleft are not
conserved. An increase in overall positive charge of the surface
of the 3-OST-1 cleft as compared with the NST-1 cleft (Fig. 5) is
consistent with the greater number of sulfo groups on the
3-OST-1 substrate than found on the NST-1 substrate (Fig. 1).
Interestingly, additional electron density was found in the elec-
tron density maps of 3-OST-1 that we have modeled as inorganic
sulfate. Residues Arg-72, Lys-123, and Lys-274 are all within
hydrogen-bonding distance to the modeled inorganic sulfate (Ta-
ble II). The position of this modeled inorganic sulfate may repre-
sent a sulfo group binding site for the HS substrate, conferring
specificity for the 3-OSTs. Consistent with this observation, mu-
tations of Lys-123 and Arg-72 (described below) result in a sig-
nificant reduction of the sulfotransferase activity (Table III).
Mutational Analysis of 3-OST-1—Site-directed mutagenesis
experiments were performed to help determine which amino
acid residues might be involved in PAPS binding, HS binding,
and/or catalysis. Eighteen different amino acid residues within
TABLE III
Summary of the analysis of 3-OST-1 mutants
The wild type m3-OST-1 was constructed by replacing N-terminal 47






3-OST-1 wild type  100.0
3-OST-1 R67E  1.1
3-OST-1 R67A  1.2
3-OST-1 K68A  0.1
3-OST-1 R72A  7.0
3-OST-1 R72E  0.0
3-OST-1 E76A  30.7
3-OST-1 E76Q  15.6
3-OST-1 E88A  63.7
3-OST-1 N89A  69.5
3-OST-1 N89D  74.4
3-OST-1 E90Q  0.0
3-OST-1 E90A  0.0
3-OST-1 H92F  0.0
3-OST-1 H92A  0.0
3-OST-1 D95A Somewhat lower than WT, detectable 0.0
3-OST-1 D95N Somewhat lower than WT, detectable 8.1
3-OST-1 W96A  91.6
3-OST-1 W96F  69.1
3-OST-1 E98A  65.6
3-OST-1 K123A  0.2
3-OST-1 K132A  49.1
3-OST-1 R197A  95.0
3-OST-1 Q163A  34.0
3-OST-1 H271A  109.0
3-OST-1 H271F  42.0
3-OST-1 S273A  99.6
3-OST-1 K274A  17.4
3-OST-1 R276A  0.3
a The mutants were prepared using site-directed mutagenesis kit
from Invitrogen. The constructs were sequenced to confirm the point
mutations. The proteins were expressed in E. coli and purified by a
nickel nitrilotriacetic acid-agarose column.
b The expression level of the proteins was determined by the intensity
of the Coomassie Blue-stained protein band migrated at 30 kDa on
SDS-PAGE.
c The activity of 3-OST-1 was determined by following a method
described in a prior publication (39), and 100% activity represents the
transfer of 14 pmol of sulfate/g of protein under the standard assay
condition.
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and around the PAPS binding site and the proposed HS bind-
ing cleft were mutated. The results of the mutagenesis study
are summarized in Table III. The positions of the mutation
sites at the active site of 3-OST-1 are shown in Fig. 6. Binding
of enzymatically modified HS to AT were compared in those
mutants that retained sulfotransferase activity. HS modified
by all of these mutants bound to AT, suggesting that these
mutant proteins maintain the substrate specificity of 3-OST-1
(data not shown). Point mutations in residues 67, 68, 72, 90, 92,
95, 123, and 276 abolish or significantly reduce the enzymatic
activity, suggesting that these residues are essential for sulfo-
transferase activity.
To help decipher the specific roles of these individual amino
acids in catalysis, binding affinity for PAP was measured and
compared with wild type using ITC analysis (Table IV). The use
of PAP as an analog for mimicking the interaction between
PAPS and sulfotransferases is a widely used approach, pro-
vided that the binding affinity of sulfotransferases to PAP is
similar to the affinity of sulfotransferase to PAPS (18). Indeed,
we determined the KD of 3-OST-1 (WT) for PAP to be 14 M,
very close to the 10 M Km of wild type 3-OST-1 for PAPS,
determined by kinetic analysis (35). Our result suggests that
the PAP binding affinity of 3-OST-1 provides a good estimate
for the binding affinity to PAPS. The binding affinity (KD
values) of the protein to PAP among the mutants K123A, R67E,
E90Q, and R72E is similar to the wild type protein, suggesting
that residues Arg-67, Arg-72, Glu-90, and Lys-123 are not
directly involved in the binding to PAP.2 However, we were
unable to accurately determine the KD values for mutants
K68A and mutant R276A because the binding affinity is too
low. We next compared the binding/elution profiles of these
proteins on a PAP-agarose column. We find that the wild type
3-OST-1 protein was eluted from the column at 1 M NaCl,
whereas 3-OST-1 K68A and 3-OST-1 R276A were eluted at 600
and 150 mM NaCl, respectively (chromatograms not shown).
These results suggest that the PAP binding affinities of
3-OST-1 K68A and 3-OST-1 R276A are indeed significantly
reduced. The decrease in the PAP binding affinity of mutant
K68A is consistent with our crystal structure data that reveals
the side chain of Lys-68 is in position to form a hydrogen bond
with the 5-phosphate of PAP. However, the reason for a de-
crease in the PAP binding affinity of mutant R276A is unclear
since the side chain of this arginine residue points away from
both the 3-phosphate and 5-phosphate of PAP.
Among those mutants that have a significant decrease in
activity, Glu-90 and Lys-123 of 3-OST-1 are conserved in
NST-1 (Glu-642 and Lys-676, respectively) and other 3-OSTs,
suggesting that these two residues serve similar functions for
the activities of these HS sulfotransferases. As described above,
the proposed function of Glu-90 of 3-OST-1 or Glu-642 of NST-1
is to serve as a catalytic base in an SN2-like in-line displace-
ment reaction. Indeed, mutations in Glu-642 of NST-1 and
Glu-90 of 3-OST-1 abolished sulfotransferase activity (34). The
crystal structure data suggest that Lys-123 in 3-OST-1 is in a
position to interact with the sulfo group of PAPS (Fig. 2b). This
interaction has also been suggested to occur in NST-1 (Lys-676)
based on modeling of PAPS into the active site (33). It is
possible that the role of Lys-123 is not to increase binding
affinity for PAPS but rather to assist in stabilizing the transi-
tion state by interacting with the equatorial oxygen atoms of
the sulfo group.
Several amino acid residues critical for the sulfotransferase
activity of 3-OST-1 are conserved in other 3-OST isoforms,
including 3-OST-1, -2, -3, -4, and -5, but are not conserved in
NSTs (36) (Fig. 4). These residues include Arg-67, Arg-72,
2 We were unable to obtain sufficient amount purified 3-OST-1
H92F, 3-OST-1 D95A, and 3-OST-1 D95N mutants for ITC analyses.
However, we purified sufficient amount of the mutant proteins to obtain
the elution profiles from PAP-agarose chromatography. Both 3-OST-1
H92F and 3-OST-1 D95N were eluted from the column at 1 M NaCl,
suggesting that the mutants have similar binding affinity to PAP as
that of wild type protein.
TABLE IV
Comparison of the thermodynamic parameters of PAP to 3-OST-1 WT and 3-OST-1 mutants as determined by ITC analysis
Protein KD
Number of
binding sites H S
M n cal/mol cal/mol
WT 14  4 0.8  0.2 1081  315 18.4
R67E 18  5 0.89  0.19 2455  600 13.0
K68Aa N/Ab N/A N/A N/A
R72E 5.2  0.8 0.8  0.04 3234  209 12.7
E90Q 5.5  2 0.68  0.27 868  428 21.0
K123A 11  2 0.72  0.07 2179  251 14.9
R276Aa N/A N/A N/A N/A
a Due to the low binding affinities between the mutants and PAP, the amount of heat release was low under the experimental conditions. Thus,
the appropriate curve fitting analysis for obtaining the KD was not feasible.
b N/A, not applicable.
FIG. 6. Stereo diagram of the hepa-
ran binding cleft of 3-OST-1. Residues
that have been mutated in this study are
shown. Mutations of residues in red abol-
ish activity, whereas mutations of resi-
dues in orange reduce the activity to 2%
of wild type. Mutations of residues in
green reduce the activity to 10% of wild
type. Mutations of residues in blue do not
significantly affect activity. For this fig-
ure the oxygen, nitrogen, and phospho-
rous atoms are colored red, blue, and ma-
genta, respectively. This figure was
created using Molscript (37) and
Raster3D (38).
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His-92, and Asp-95.3 This observation suggests that these res-
idues contribute to the substrate specificity of 3-O-sulfotrans-
ferases. At the present time, it is unclear how these amino acid
residues contribute to the substrate specificity, namely how
3-OST sulfonates the 3-OH position, whereas NST sulfonates
the 2-amino position of the glucosamine unit. In addition, a
possible catalytic role for residues His-92 and Asp-95 cannot be
ruled out. Atom NE2 of His-92 from 3-OST-1 is only 3.3 Å away
from a carboxylate oxygen atom of the proposed base Glu-90.
Additionally, Asp-95 forms a hydrogen bond with ND1 of His-
92. This sequence of residues (Glu-90– His-92–Asp-95) pro-
vides for a potential hydrogen-bonding network. Supporting
this hypothesis, the mutant D95N, which could geometrically
maintain the hydrogen-bonding network, does retain some sul-
fotransferase activity, whereas the D95A mutant does not (Ta-
ble III). Interestingly in NST-1, Gln-644 is within hydrogen-
bonding distance of Glu-642 (3.1 Å) the proposed base. The
mutant Q644A also shows a significant loss of activity, suggest-
ing a similar role to His-92 in 3-OST-1 for catalytic function.
This proposed hydrogen bonding network could either provide
activation for the glutamate as the base for catalysis or simply
play a structural role by orienting the base in the proper
conformation for catalysis.
The positions of residues Arg-67 and Arg-72 do not appear to
support a role in catalysis. In NST-1, the corresponding resi-
dues are Gln-613 and Thr-618, respectively. The positive
charge on these arginine residues in 3-OST-1 may assist in the
interaction of these residues with negatively charged sulfo
groups on the HS substrate. As previously mentioned, Arg-72
lies within hydrogen-bonding distance of the free inorganic
sulfate modeled into the electron density. To fully understand
the role of these residues and others in 3-OST-1 substrate
binding, a ternary complex with both HS and PAP bound to
3-OST-1 will be required.
In conclusion, we have presented the results from the study
of a crystal structure of the binary complex of 3-OST-1 and PAP
and mutational analysis. Comparing the current structure of
3-OST-1 with the previously published structure of NST-1,
several amino acid residues have been identified that may play
a role in directing the substrate specificity of HS sulfotrans-
ferases. Because 3-OST is present in six different isoforms and
the 3-OST-modified HS pose distinct biological activities, a
remaining challenge is to understand the mechanism employed
by the different isoforms to distinguish the saccharide sequence
of their unique substrates. From the present study we are
unable to reveal the precise molecular details of the substrate
specificity differences between the 3-OSTs. Although the pres-
ent study does not reveal the mechanism of substrate specific-
ity differences between the 3-OSTs, the results from this study
provide valuable structural information toward a comprehen-
sive understanding of HS biosynthesis.
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